Sign Up to like & get
recommendations!
1
Published in 2018 at "STEM CELLS Translational Medicine"
DOI: 10.1002/sctm.12357
Abstract: Background: AMR-001, an autologous CD34+ cell product derived from mini-marrow harvest, is currently undergoing Phase II trials to treat acute myocardial infarction (AMI). At the time of AMR-001 infusion, it is believed that the infarct-region…
read more here.
Keywords:
mobilized cells;
cord blood;
cord;
non mobilized ... See more keywords